Free Trial
NASDAQ:NTRBW

Nutriband (NTRBW) Stock Price, News & Analysis

$1.00
0.00 (0.00%)
(As of 07/12/2024 ET)
Today's Range
$1.00
$1.00
50-Day Range
$0.55
$1.32
52-Week Range
$0.19
$1.51
Volume
N/A
Average Volume
10,127 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NTRBW stock logo

About Nutriband Stock (NASDAQ:NTRBW)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRBW Stock Price History

NTRBW Stock News Headlines

See More Headlines
Receive NTRBW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:NTRBW
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.02 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Serguei Melnik (Age 50)
    Founder, President, Company Secretary & Executive Chairman of the Board
    Comp: $175k
  • Mr. Gareth Sheridan (Age 34)
    Founder, CEO & Director
    Comp: $175k
  • Mr. Gerald Goodman (Age 76)
    CFO & Chief Accounting Officer
    Comp: $140k
  • Dr. Alan Smith Ph.D. (Age 58)
    COO & President of 4P Therapeutics
    Comp: $159k
  • Dr. Jeffrey Patrick Pharm.D. (Age 54)
    Chief Scientific Officer
  • Mr. Michael Myer (Age 39)
    President of Pocono Pharmaceutical
    Comp: $40.6k
  • Mr. Tyler Overk (Age 40)
    Head of Active Intelligence

NTRBW Stock Analysis - Frequently Asked Questions

How have NTRBW shares performed this year?

Nutriband's stock was trading at $0.36 at the start of the year. Since then, NTRBW stock has increased by 177.8% and is now trading at $1.00.
View the best growth stocks for 2024 here
.

How do I buy shares of Nutriband?

Shares of NTRBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRBW) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners